Report Detail
Global Colon & Rectal Carcinoma Market Professional Survey Report 2019
- RnM3811888 |
- 11 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together.
The global Colon & Rectal Carcinoma market was valued at 8500 million US$ in 2018 and will reach 9880 million US$ by the end of 2025, growing at a CAGR of 1.9% during 2019-2025.
This report focuses on Colon & Rectal Carcinoma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colon & Rectal Carcinoma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Colon & Rectal Carcinoma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Colon & Rectal Carcinoma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Colon
Rectal
Segment by Application
Hospital
Clinic
Table of Contents
Executive Summary
1 Industry Overview of Colon & Rectal Carcinoma
- 1.1 Definition of Colon & Rectal Carcinoma
- 1.2 Colon & Rectal Carcinoma Segment by Type
- 1.2.1 Global Colon & Rectal Carcinoma Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Colon
- 1.2.3 Rectal
- 1.3 Colon & Rectal Carcinoma Segment by Applications
- 1.3.1 Global Colon & Rectal Carcinoma Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Global Colon & Rectal Carcinoma Overall Market
- 1.4.1 Global Colon & Rectal Carcinoma Revenue (2014-2025)
- 1.4.2 Global Colon & Rectal Carcinoma Production (2014-2025)
- 1.4.3 North America Colon & Rectal Carcinoma Status and Prospect (2014-2025)
- 1.4.4 Europe Colon & Rectal Carcinoma Status and Prospect (2014-2025)
- 1.4.5 China Colon & Rectal Carcinoma Status and Prospect (2014-2025)
- 1.4.6 Japan Colon & Rectal Carcinoma Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Colon & Rectal Carcinoma Status and Prospect (2014-2025)
- 1.4.8 India Colon & Rectal Carcinoma Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Colon & Rectal Carcinoma
- 2.3 Manufacturing Process Analysis of Colon & Rectal Carcinoma
- 2.4 Industry Chain Structure of Colon & Rectal Carcinoma
3 Development and Manufacturing Plants Analysis of Colon & Rectal Carcinoma
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Colon & Rectal Carcinoma Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Colon & Rectal Carcinoma
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Colon & Rectal Carcinoma Production and Capacity Analysis
- 4.2 Colon & Rectal Carcinoma Revenue Analysis
- 4.3 Colon & Rectal Carcinoma Price Analysis
- 4.4 Market Concentration Degree
5 Colon & Rectal Carcinoma Regional Market Analysis
- 5.1 Colon & Rectal Carcinoma Production by Regions
- 5.1.1 Global Colon & Rectal Carcinoma Production by Regions
- 5.1.2 Global Colon & Rectal Carcinoma Revenue by Regions
- 5.2 Colon & Rectal Carcinoma Consumption by Regions
- 5.3 North America Colon & Rectal Carcinoma Market Analysis
- 5.3.1 North America Colon & Rectal Carcinoma Production
- 5.3.2 North America Colon & Rectal Carcinoma Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Colon & Rectal Carcinoma Import and Export
- 5.4 Europe Colon & Rectal Carcinoma Market Analysis
- 5.4.1 Europe Colon & Rectal Carcinoma Production
- 5.4.2 Europe Colon & Rectal Carcinoma Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Colon & Rectal Carcinoma Import and Export
- 5.5 China Colon & Rectal Carcinoma Market Analysis
- 5.5.1 China Colon & Rectal Carcinoma Production
- 5.5.2 China Colon & Rectal Carcinoma Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Colon & Rectal Carcinoma Import and Export
- 5.6 Japan Colon & Rectal Carcinoma Market Analysis
- 5.6.1 Japan Colon & Rectal Carcinoma Production
- 5.6.2 Japan Colon & Rectal Carcinoma Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Colon & Rectal Carcinoma Import and Export
- 5.7 Southeast Asia Colon & Rectal Carcinoma Market Analysis
- 5.7.1 Southeast Asia Colon & Rectal Carcinoma Production
- 5.7.2 Southeast Asia Colon & Rectal Carcinoma Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Colon & Rectal Carcinoma Import and Export
- 5.8 India Colon & Rectal Carcinoma Market Analysis
- 5.8.1 India Colon & Rectal Carcinoma Production
- 5.8.2 India Colon & Rectal Carcinoma Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Colon & Rectal Carcinoma Import and Export
6 Colon & Rectal Carcinoma Segment Market Analysis (by Type)
- 6.1 Global Colon & Rectal Carcinoma Production by Type
- 6.2 Global Colon & Rectal Carcinoma Revenue by Type
- 6.3 Colon & Rectal Carcinoma Price by Type
7 Colon & Rectal Carcinoma Segment Market Analysis (by Application)
- 7.1 Global Colon & Rectal Carcinoma Consumption by Application
- 7.2 Global Colon & Rectal Carcinoma Consumption Market Share by Application (2014-2019)
8 Colon & Rectal Carcinoma Major Manufacturers Analysis
- 8.1 Pfizer
- 8.1.1 Pfizer Colon & Rectal Carcinoma Production Sites and Area Served
- 8.1.2 Pfizer Product Introduction, Application and Specification
- 8.1.3 Pfizer Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Bayer Healthcare
- 8.2.1 Bayer Healthcare Colon & Rectal Carcinoma Production Sites and Area Served
- 8.2.2 Bayer Healthcare Product Introduction, Application and Specification
- 8.2.3 Bayer Healthcare Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Spectrum
- 8.3.1 Spectrum Colon & Rectal Carcinoma Production Sites and Area Served
- 8.3.2 Spectrum Product Introduction, Application and Specification
- 8.3.3 Spectrum Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis
- 8.4.1 Novartis Colon & Rectal Carcinoma Production Sites and Area Served
- 8.4.2 Novartis Product Introduction, Application and Specification
- 8.4.3 Novartis Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Amgen
- 8.5.1 Amgen Colon & Rectal Carcinoma Production Sites and Area Served
- 8.5.2 Amgen Product Introduction, Application and Specification
- 8.5.3 Amgen Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Roche
- 8.6.1 Roche Colon & Rectal Carcinoma Production Sites and Area Served
- 8.6.2 Roche Product Introduction, Application and Specification
- 8.6.3 Roche Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Merck
- 8.7.1 Merck Colon & Rectal Carcinoma Production Sites and Area Served
- 8.7.2 Merck Product Introduction, Application and Specification
- 8.7.3 Merck Colon & Rectal Carcinoma Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Colon & Rectal Carcinoma Market
- 9.1 Global Colon & Rectal Carcinoma Market Trend Analysis
- 9.1.1 Global Colon & Rectal Carcinoma Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Colon & Rectal Carcinoma Regional Market Trend
- 9.2.1 North America Colon & Rectal Carcinoma Forecast 2019-2025
- 9.2.2 Europe Colon & Rectal Carcinoma Forecast 2019-2025
- 9.2.3 China Colon & Rectal Carcinoma Forecast 2019-2025
- 9.2.4 Japan Colon & Rectal Carcinoma Forecast 2019-2025
- 9.2.5 Southeast Asia Colon & Rectal Carcinoma Forecast 2019-2025
- 9.2.6 India Colon & Rectal Carcinoma Forecast 2019-2025
- 9.3 Colon & Rectal Carcinoma Market Trend (Product Type)
- 9.4 Colon & Rectal Carcinoma Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Colon & Rectal Carcinoma Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Colon & Rectal Carcinoma. Industry analysis & Market Report on Colon & Rectal Carcinoma is a syndicated market report, published as Global Colon & Rectal Carcinoma Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Colon & Rectal Carcinoma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
